BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• FDA Approves Next Generation Actonel for the Treatment of Postmenopausal Osteoporosis

  October 11, 2010

   · 

  1 min read
• Drug Development

  Allos Therapeutics, Inc. Announces Presentation of Favorable Survival Data from Randomized Phase 2b Study of FOLOTYN(R) in Patients with Advanced Non-Small Cell Lung Cancer

  October 11, 2010

   · 

  1 min read
• Pharm Country

  BrainStorm Cell Therapeutics Inc. Receives Approval to Begin Clinical Trial of Adult Stem Cell Therapy in Patients with ALS

  October 11, 2010

   · 

  1 min read
• Drug Development

  ArQule, Inc. Release: Presentation at ESMO Highlights Anti-Metastatic Effects of ARQ 197 c-MET Inhibitor in Non-Small Cell Lung Cancer

  October 11, 2010

   · 

  1 min read
• FDA Identifies Safety Issue with Carboplatin Dosing

  October 11, 2010

   · 

  1 min read
• BioMidwest

  BioSante Pharmaceuticals, Inc. Presents LibiGel(R) Clinical Study Update at North American Menopause Society Meeting

  October 11, 2010

   · 

  1 min read
• Methotrexate Appears to Protect Against Uveitis in JIA

  October 11, 2010

   · 

  1 min read
• Children’s Agitation After Surgery May Be Preventable

  October 11, 2010

   · 

  1 min read
• Drug Development

  Curis, Inc. Announces Genentech’s Initiation of Phase II Trial for GDC-0449 in Operable Basal Cell Carcinoma

  October 11, 2010

   · 

  1 min read
• Drug Development

  Merck Serono Release: Results of a Randomized Phase II Study with Erbitux in Breast Cancer Highlighted in ESMO 2010 Presidential Symposium

  October 11, 2010

   · 

  1 min read